How many years of comparable data are there for Bosnia and Herzegovina and Oman?

5 years are reported by both, from 2017 to 2022.

Where does this data come from?

World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Bosnia and Herzegovina vs Oman: Share of S. aureus infections resistant to methicillin

Bosnia and Herzegovina

26.5%

in 2022

Oman

28.6%

in 2022

Bosnia and Herzegovina rank

23rd

Oman rank

21st

Share of S. aureus infections resistant to methicillin over time

Bosnia and Herzegovina
Oman

How they compare

Oman currently reports 28.6% against 26.5% in Bosnia and Herzegovina, a difference of 2.1%.

That makes Oman's figure about 1.1 times Bosnia and Herzegovina's.

Across all 5 years both countries report, Oman has been ahead every year.

Bosnia and Herzegovina ranks 23rd and Oman ranks 21st of 45 countries.

Oman has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade	Bosnia and Herzegovina	Oman	Difference	Ahead
2010s	21.1%	45.5%	24.5%	Oman
2020s	23.5%	33.9%	10.4%	Oman

Averages of every year both report within each decade.

Frequently asked questions

Which has higher share of s. aureus infections resistant to methicillin, Bosnia and Herzegovina or Oman?: Oman, at 28.6% against 26.5% in Bosnia and Herzegovina as of 2022.
What is the difference in share of s. aureus infections resistant to methicillin between Bosnia and Herzegovina and Oman?: 2.1%, with Oman ahead.
How many years of comparable data are there for Bosnia and Herzegovina and Oman?: 5 years are reported by both, from 2017 to 2022.
How do Bosnia and Herzegovina and Oman rank globally for share of s. aureus infections resistant to methicillin?: Bosnia and Herzegovina ranks 23rd and Oman ranks 21st of 45 countries.
Where does this data come from?: World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bosnia and Herzegovina vs Oman: Share of S. aureus infections resistant to methicillin. Statizoid, drawing on World Health Organization – processed by Our World in Data. Retrieved 15 September 2026, from https://reference.statizoid.com/compare/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/bosnia-and-herzegovina/oman/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/compare/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/bosnia-and-herzegovina/oman/">Bosnia and Herzegovina vs Oman: Share of S. aureus infections resistant to methicillin</a> — Statizoid

About this data

Indicator: Share of S. aureus infections resistant to methicillin
Unit: %
Source: World Health Organization – processed by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 45 places, 273 data points, 2016–2022
Last refreshed: 28 August 2026

Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).